tamoxifen 中文意思是什麼
tamoxifen
解釋
tam三苯氧胺-
Of those, 96 were prescribed tamoxifen, a drug therapy considered one of the best options for blocking the hormones that promote cancerous cell growth
其中， 96名患者正在服用三苯氧胺，這種藥物治療被認為是阻斷促進癌細胞生長的激素的最佳方案之一。 -
Conclusions the recurrence score has been vakidated as quantifying the kikekihood of distant recurrence in tamoxifen - treated patients with node - negative ? estrogen - receptor - positive breast cancer
結論研究證實復發評分可量化淋巴結陰性、雌激素受體陽性、接受他莫昔芬治療的乳腺癌患者的遠處復發可能性。 -
Because the irish study looked only at prescription records and not diagnoses, medical records, or the patients themselves, the researchers could not fully explore why women stopped taking tamoxifen
因為愛爾蘭的研究只是調查了處方記錄，而不是診斷，醫療文件或患者本身，研究者不能完全的了解為什麼婦女停止服用他莫西芬。 -
One study is a multinational adjuvant ( post - operative ) clinical trial evaluating disease - free and overall survival in women with breast cancer who take femara after having remained disease - free with five years of tamoxifen therapy
一項研究是多國輔藥（術后）臨床試驗，用以評估乳癌患者服用弗隆后的無瘤生存率和整體生存率，這些女患者之前已進行了5年的他莫昔芬治療，一直未發病。 -
Tamoxifen approved by fda for marketing as a treatment drug
Fda批準他末昔芬作為治療藥物進入市場 -
Breast cancer preention trial begins, testing tamoxifen, a cancer treatment drug, as a preentie agent in women at increased risk of the disease
乳腺癌預防試驗開始，證實治療藥物他莫昔芬在高風險女性人群中的預防作用 -
Breast cancer prevention trial begins, testing tamoxifen, a cancer treatment drug, as a preventive agent in women at increased risk of the disease
乳腺癌預防試驗開始，證實治療藥物他莫昔芬在高風險女性人群中的預防作用 -
1998 women at increased risk of deeloping breast cancer shown to reduce the chance of deeloping breast cancer by half by taking tamoxifen in the breast cancer preention trial
1998年，他莫昔芬乳腺癌預防試驗表明高風險患者的發病機會降低一半 -
A second trial compares five years of femara to five years of tamoxifen, and to the sequence of two years of femara and three years of tamoxifen or the reverse - two years of tamoxifen and three years of femara
另一試驗將5年弗隆治療分別與5年他莫昔芬治療，先2年弗隆后3年他莫昔芬治療或先2年他莫昔芬后3年弗隆治療，進行了比較。 -
Many women stop tamoxifen therapy well before their 5 - year course is up. learning the reasons why is important to developing interventions
許多婦女在她們的5年治療期結束前停用他莫西芬。了解開展干預治療重要性的原因。 -
The gonads of some southern catfish developed relatively slower than normal fish under the effect of tamoxifen after the histological dissection of 48 dah fish
48dah組織學結果顯示， tamoxifen處理引起南方鯰一部分性腺發育遲緩，處于未分化狀態。 -
Now, tamoxifen is still the standard endocrine therapeutic drug or the premenopausal patients, but aromatase inhibitors can bring more benefit for the postmenopausal patients
目前，三苯氧胺對絕經前患者仍是內分泌治療的標準用藥，但對絕經後患者應用芳香化酶抑制劑會有更大的效益。 -
Women who had used antidepressants in the year before starting tamoxifen were also more likely to quit ( hr 1. 41 )
在開始使用他莫西芬前一年內使用過抗抑鬱藥的婦女也容易停藥（風險比1 . 41 ） 。 -
Despite this risk, tamoxifen and another drug in this class, raloxifene, remain an extensively used and popular treatment
雖然存在這些副作用，三苯氧胺和另一種同類藥物雷洛西芬已經被廣泛用於乳腺癌的治療。 -
Breast density is primarily inherited, but hormone replacement therapy can increase density, while the breast cancer drug tamoxifen decreases it
乳房的密度大小主要是遺傳引起，但是激素替代治療可以增加密度，而乳腺癌藥物它莫西芬可以降低密度。 -
Anti - estrogen drugs such as tamoxifen ( noaldex ) are a standard treatment for hormone - dependent breast cancer
抗雌激素* *物如他莫昔酚是激素依賴性乳癌的標準治療。 -
Anti - estrogen drugs such as tamoxifen ( novaldex ) are a standard treatment for hormone - dependent breast cancer
抗雌激素藥物如他莫昔酚是激素依賴性乳癌的標準治療。 -
Tamoxifen was the first estrogen modulator shown to increase survival and reduce the risk of breast cancer recurrence
三苯氧胺是第一個雌激素調節劑，可增加患者的生存率和降低乳腺癌復發的危險。 -
Progress of research of the mechanism of tamoxifen resistance in breast cancer
乳腺癌三苯氧胺耐藥機制的研究進展 -
Reversal of multidrug resistance in leukemia cell line by cyclosporin a combining with tamoxifen and interferon
02細胞多藥耐藥機制的研究
分享友人